OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Statement on safety of cannabidiol as a novel food: data gaps and uncertainties
Dominique Turck, Torsten Bohn, Jacqueline Castenmiller, et al.
EFSA Journal (2022) Vol. 20, Iss. 6
Open Access | Times Cited: 49
Dominique Turck, Torsten Bohn, Jacqueline Castenmiller, et al.
EFSA Journal (2022) Vol. 20, Iss. 6
Open Access | Times Cited: 49
Showing 26-50 of 49 citing articles:
Ultrasound-assisted dispersive solid-liquid microextraction with eutectic solvents for the determination of cannabinoids in different hemp products
Giulia Mastellone, Arianna Marengo, Barbara Sgorbini, et al.
Journal of Chromatography B (2023) Vol. 1232, pp. 123967-123967
Open Access | Times Cited: 5
Giulia Mastellone, Arianna Marengo, Barbara Sgorbini, et al.
Journal of Chromatography B (2023) Vol. 1232, pp. 123967-123967
Open Access | Times Cited: 5
Safety and risks of CBD oils purchased online: unveiling uncertain quality and vague health claims
Róbert György Vida, Lilien Victoria Strauss, Ákos Bajtel, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 5
Róbert György Vida, Lilien Victoria Strauss, Ákos Bajtel, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 5
Pharmacological and morphological features and socioeconomic aspects of cannabidiol: A literature review
Oles-Pylyp Hasiuk
International Journal of Medicine and Medical Research (2023), pp. 47-59
Open Access | Times Cited: 4
Oles-Pylyp Hasiuk
International Journal of Medicine and Medical Research (2023), pp. 47-59
Open Access | Times Cited: 4
A systematic review of analytical methodologies capable of analysing phytocannabinoids in cosmetics
Bart Desmedt, Peter Van Campenhout, Eric Deconinck
Drug Testing and Analysis (2024)
Closed Access | Times Cited: 1
Bart Desmedt, Peter Van Campenhout, Eric Deconinck
Drug Testing and Analysis (2024)
Closed Access | Times Cited: 1
Cannabidiol in anxiety disorders: Current and future perspectives
João Luís Q. Simei, José Diogo R. Souza, João Roberto Lisboa, et al.
International review of neurobiology (2024), pp. 205-234
Closed Access | Times Cited: 1
João Luís Q. Simei, José Diogo R. Souza, João Roberto Lisboa, et al.
International review of neurobiology (2024), pp. 205-234
Closed Access | Times Cited: 1
Genotoxicity of selected cannabinoids in human lymphoblastoid TK6 cells
Nicol Kolar, Ezgi Eyluel Bankoglu, Helga Stopper
Archives of Toxicology (2024) Vol. 98, Iss. 10, pp. 3439-3451
Open Access | Times Cited: 1
Nicol Kolar, Ezgi Eyluel Bankoglu, Helga Stopper
Archives of Toxicology (2024) Vol. 98, Iss. 10, pp. 3439-3451
Open Access | Times Cited: 1
Updated Risk Assessment of Cannabidiol in Foods Based on Benchmark Dose–Response Modeling
Eva Wisotzki, Heike Franke, Constanze Sproll, et al.
Molecules (2024) Vol. 29, Iss. 19, pp. 4733-4733
Open Access | Times Cited: 1
Eva Wisotzki, Heike Franke, Constanze Sproll, et al.
Molecules (2024) Vol. 29, Iss. 19, pp. 4733-4733
Open Access | Times Cited: 1
The Challenge of Risk Assessment of Tetrahydrocannabinol (THC) in Cannabidiol (CBD) Oils and Food Supplements: An Approach for Deriving Maximum Limits
Sandra Schweikle, Patricia Golombek, Constanze Sproll, et al.
Challenges (2022) Vol. 13, Iss. 2, pp. 32-32
Open Access | Times Cited: 7
Sandra Schweikle, Patricia Golombek, Constanze Sproll, et al.
Challenges (2022) Vol. 13, Iss. 2, pp. 32-32
Open Access | Times Cited: 7
Cannabidiol and pharmacokinetics drug-drug interactions: Pharmacological toolbox
Clémence Lacroix, Romain Guilhaumou, Joëlle Micallef, et al.
Therapies (2023) Vol. 79, Iss. 3, pp. 351-363
Closed Access | Times Cited: 3
Clémence Lacroix, Romain Guilhaumou, Joëlle Micallef, et al.
Therapies (2023) Vol. 79, Iss. 3, pp. 351-363
Closed Access | Times Cited: 3
Are adverse effects of cannabidiol (CBD) products caused by tetrahydrocannabinol (THC) contamination?
Dirk W. Lachenmeier, Stephanie Habel, Berit Fischer, et al.
F1000Research (2022) Vol. 8, pp. 1394-1394
Open Access | Times Cited: 5
Dirk W. Lachenmeier, Stephanie Habel, Berit Fischer, et al.
F1000Research (2022) Vol. 8, pp. 1394-1394
Open Access | Times Cited: 5
Are adverse effects of cannabidiol (CBD) products caused by tetrahydrocannabinol (THC) contamination?
Dirk W. Lachenmeier, Stephanie Habel, Berit Fischer, et al.
F1000Research (2024) Vol. 8, pp. 1394-1394
Open Access
Dirk W. Lachenmeier, Stephanie Habel, Berit Fischer, et al.
F1000Research (2024) Vol. 8, pp. 1394-1394
Open Access
Selected nutritional supplements
Adam Killpartrick, Kalev Freeman, Mary McHenry, et al.
Elsevier eBooks (2024), pp. 185-246
Closed Access
Adam Killpartrick, Kalev Freeman, Mary McHenry, et al.
Elsevier eBooks (2024), pp. 185-246
Closed Access
Study on knowledge and perceptions on the uptake of non-medicinal Cannabis-substances and preparations by Portuguese consumers: borderline issues
Alexandre Elias, Catarina Rosado, Maria do Céu Costa
Heliyon (2024) Vol. 10, Iss. 24, pp. e40827-e40827
Open Access
Alexandre Elias, Catarina Rosado, Maria do Céu Costa
Heliyon (2024) Vol. 10, Iss. 24, pp. e40827-e40827
Open Access
Cannabinoids for treating psychiatric disorders in youth: a systematic review of randomized controlled trials
Patrick Köck, Andrzej Badek, Maximilian Meyer, et al.
Child and Adolescent Psychiatry and Mental Health (2024) Vol. 18, Iss. 1
Open Access
Patrick Köck, Andrzej Badek, Maximilian Meyer, et al.
Child and Adolescent Psychiatry and Mental Health (2024) Vol. 18, Iss. 1
Open Access
Safety assessment on CBD-rich hemp extract in sub-chronic cross-sex study with rats
Jan Dehner, Hana Polanská, Kateřina Petrláková, et al.
Toxicology and Applied Pharmacology (2024) Vol. 495, pp. 117218-117218
Closed Access
Jan Dehner, Hana Polanská, Kateřina Petrláková, et al.
Toxicology and Applied Pharmacology (2024) Vol. 495, pp. 117218-117218
Closed Access
Application of the precautionary principle under article 7 of Regulation (EC) No 178/2002: general principles and evaluation of cannabidiol in food
Constanze Sproll, Stephan G. Walch, Dirk W. Lachenmeier
Journal of Consumer Protection and Food Safety (2023) Vol. 18, Iss. 4, pp. 361-374
Open Access | Times Cited: 1
Constanze Sproll, Stephan G. Walch, Dirk W. Lachenmeier
Journal of Consumer Protection and Food Safety (2023) Vol. 18, Iss. 4, pp. 361-374
Open Access | Times Cited: 1
Pharmacovigilance of unlicensed cannabidiol in European countries
Fabrizio Calapai, Emanuela Esposito, Ilaria Ammendolia, et al.
Phytotherapy Research (2023)
Open Access | Times Cited: 1
Fabrizio Calapai, Emanuela Esposito, Ilaria Ammendolia, et al.
Phytotherapy Research (2023)
Open Access | Times Cited: 1
Does Cannabidiol (CBD) in Food Supplements Pose a Serious Health Risk? Consequences of the EFSA Clock Stop Regarding Novel Food Authorisation
Dirk W. Lachenmeier, Constanze Sproll, Patricia Golombek, et al.
(2022)
Open Access | Times Cited: 2
Dirk W. Lachenmeier, Constanze Sproll, Patricia Golombek, et al.
(2022)
Open Access | Times Cited: 2
Does Cannabidiol (CBD) in Food Supplements Pose a Serious Health Risk? Consequences of the EFSA Clock Stop Regarding Novel Food Authorisation
Dirk W. Lachenmeier, Constanze Sproll, Patricia Golombek, et al.
(2022)
Open Access | Times Cited: 2
Dirk W. Lachenmeier, Constanze Sproll, Patricia Golombek, et al.
(2022)
Open Access | Times Cited: 2
A review of studies evaluating medical cannabis for the chronic pain management
Justyna Żyga
Journal of Education Health and Sport (2022) Vol. 12, Iss. 8, pp. 250-256
Open Access | Times Cited: 1
Justyna Żyga
Journal of Education Health and Sport (2022) Vol. 12, Iss. 8, pp. 250-256
Open Access | Times Cited: 1
Does Cannabidiol (CBD) in Food Supplements Pose a Serious Health Risk? Consequences of the EFSA Clock Stop Regarding Novel Food Authorisation
Dirk W. Lachenmeier, Constanze Sproll, Patricia Golombek, et al.
(2022)
Open Access | Times Cited: 1
Dirk W. Lachenmeier, Constanze Sproll, Patricia Golombek, et al.
(2022)
Open Access | Times Cited: 1
S04-03: CBD Regulatory and safety aspects
Barbara Engeli
Toxicology Letters (2023) Vol. 384, pp. S24-S25
Closed Access
Barbara Engeli
Toxicology Letters (2023) Vol. 384, pp. S24-S25
Closed Access
Ibrahim Bechri, Ali Derkaoui, Abdelkarim Shimi, et al.
International Journal of Medicine and Medical Research (2023) Vol. 9, Iss. 1
Open Access
Food Toxicology and Food Safety: Report of the 3rd International Electronic Conference on Foods: Food, Microbiome, and Health—A Celebration of the 10th Anniversary of Foods’ Impact on Our Wellbeing
Dirk W. Lachenmeier, Paula A. Oliveira, Agata Fabiszewska, et al.
Foods (2022) Vol. 11, Iss. 24, pp. 4099-4099
Open Access
Dirk W. Lachenmeier, Paula A. Oliveira, Agata Fabiszewska, et al.
Foods (2022) Vol. 11, Iss. 24, pp. 4099-4099
Open Access
